White Paper Exposes Delay, Waste, and Cancer Treatment Obstacles Imposed on Patients by Pharmacy Benefit Managers

A new white paper released today by the Community Oncology Alliance (COA) and the Community Oncology Pharmacy Association (COPA) exposes the negative impact pharmacy benefit managers (PBMs) have on the care cancer patients receive.

Compiling real stories of cancer patients and physicians, the white paper “Delay, Waste, and Cancer Treatment Obstacles: The Real-Life Patient Impact of Pharmacy Benefit Managers (PBM)” was released today at the opening of the 2017 Community Oncology Conference.

Presenting true patient stories collected from community oncology practices over the last year, the white paper details common PBM practices that have a negative impact on cancer patient care. The serious, sometimes dangerous, stories told in the paper include the delay of treatment for as much as six weeks, unaccountable PBM bureaucracies, unethical business practices, and incredible waste.

Read the story here

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, April 27, 2017 /EINPresswire.com/